Rocket Pharmaceuticals, Inc. (RCKT)
2.54
+0.16
(+6.50%)
USD |
NASDAQ |
Nov 09, 16:00
2.54
0.00 (0.00%)
After-Hours: 19:48
Rocket Pharmaceuticals Total Return Level : 2.385 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.385 |
| November 05, 2026 | 2.435 |
| November 04, 2026 | 2.61 |
| November 03, 2026 | 2.51 |
| November 02, 2026 | 2.47 |
| October 30, 2026 | 2.44 |
| October 29, 2026 | 2.54 |
| October 28, 2026 | 2.58 |
| October 27, 2026 | 2.45 |
| October 26, 2026 | 2.28 |
| October 23, 2026 | 2.29 |
| October 22, 2026 | 2.31 |
| October 21, 2026 | 2.20 |
| October 20, 2026 | 2.34 |
| October 19, 2026 | 2.24 |
| October 16, 2026 | 2.18 |
| October 15, 2026 | 2.36 |
| October 14, 2026 | 2.21 |
| October 13, 2026 | 2.30 |
| October 12, 2026 | 2.48 |
| October 09, 2026 | 2.56 |
| October 08, 2026 | 2.63 |
| October 07, 2026 | 2.535 |
| October 06, 2026 | 2.48 |
| October 05, 2026 | 2.61 |
| Date | Value |
|---|---|
| October 02, 2026 | 2.56 |
| October 01, 2026 | 2.59 |
| September 30, 2026 | 2.63 |
| September 29, 2026 | 2.59 |
| September 28, 2026 | 2.61 |
| September 25, 2026 | 2.595 |
| September 24, 2026 | 2.69 |
| September 23, 2026 | 3.02 |
| September 22, 2026 | 3.35 |
| September 21, 2026 | 3.27 |
| September 18, 2026 | 3.37 |
| September 17, 2026 | 3.50 |
| September 16, 2026 | 3.48 |
| September 15, 2026 | 3.41 |
| September 14, 2026 | 3.43 |
| September 11, 2026 | 3.35 |
| September 10, 2026 | 3.48 |
| September 09, 2026 | 3.63 |
| September 08, 2026 | 3.71 |
| September 04, 2026 | 3.86 |
| September 03, 2026 | 3.79 |
| September 02, 2026 | 3.86 |
| September 01, 2026 | 3.73 |
| August 31, 2026 | 3.72 |
| August 28, 2026 | 3.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Sarepta Therapeutics, Inc. | 17.82 |
| Intellia Therapeutics, Inc. | 11.35 |
| Beam Therapeutics, Inc. | 26.41 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |